Cancer data helps in identifying specific molecular targets for treatment. For instance, next-generation sequencing can reveal mutations in genes like BRCA1 and BRCA2, allowing for targeted therapies such as PARP inhibitors. Similarly, data on protein expression levels can guide the use of monoclonal antibodies to inhibit specific pathways in cancer cells.
